AAAAAA
Results:
1-15
|
Results: 15
Authors:
Finn, OJ
Lotze, MT
Citation: Oj. Finn et Mt. Lotze, A decade in the life of tumor immunology, CLIN CANC R, 7(3), 2001, pp. 759S-760S
Authors:
Kao, H
Amoscato, AA
Ciborowski, P
Finn, OJ
Citation: H. Kao et al., A new strategy for tumor antigen discovery based on in vitro priming of naive T cells with dendritic cells, CLIN CANC R, 7(3), 2001, pp. 773S-780S
Authors:
Beatty, P
Hanisch, FG
Stolz, DB
Finn, OJ
Ciborowski, P
Citation: P. Beatty et al., Biochemical characterization of the soluble form of tumor antigen MUC1 isolated from sera and ascites fluid of breast and pancreatic cancer patients, CLIN CANC R, 7(3), 2001, pp. 781S-787S
Authors:
Schmielau, J
Nalesnik, MA
Finn, OJ
Citation: J. Schmielau et al., Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients, CLIN CANC R, 7(3), 2001, pp. 933S-939S
Authors:
Soares, M
Hanisch, FG
Finn, OJ
Ciborowski, P
Citation: M. Soares et al., Recombinant human tumor antigen MUC1 expressed in insect cells: Structure and immunogenicity, PROT EX PUR, 22(1), 2001, pp. 92-100
Authors:
Soares, MM
Mehta, V
Finn, OJ
Citation: Mm. Soares et al., Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection, J IMMUNOL, 166(11), 2001, pp. 6555-6563
Authors:
Kao, H
Marto, JA
Hoffman, TK
Shabanowitz, J
Finkelstein, SD
Whiteside, TL
Hunt, DF
Finn, OJ
Citation: H. Kao et al., Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells, J EXP MED, 194(9), 2001, pp. 1313-1323
Authors:
Schmielau, J
Finn, OJ
Citation: J. Schmielau et Oj. Finn, Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients, CANCER RES, 61(12), 2001, pp. 4756-4760
Authors:
Soares, M
Finn, OJ
Citation: M. Soares et Oj. Finn, MUC1 mucin as a target for immunotherapy of cancer: Muc1 based immunotherapeutic strategies, IMMUNOL MED, 30, 2001, pp. 101-122
Authors:
Hiltbold, EM
Vlad, AM
Ciborowski, P
Watkins, SC
Finn, OJ
Citation: Em. Hiltbold et al., The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells, J IMMUNOL, 165(7), 2000, pp. 3730-3741
Authors:
McKolanis, JR
Finn, OJ
Citation: Jr. Mckolanis et Oj. Finn, Analysis of the frequency of MHC-unrestricted MUC1-specific cytotoxic T-cells in peripheral blood by limiting dilution assay, METH MOL B, 125, 2000, pp. 463-470
Authors:
Ciborowski, P
Finn, OJ
Citation: P. Ciborowski et Oj. Finn, Expression of MUC1 in insect cells using recombinant baculovirus, METH MOL B, 125, 2000, pp. 471-486
Authors:
Barratt-Boyes, SM
Vlad, A
Finn, OJ
Citation: Sm. Barratt-boyes et al., Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses, CLIN CANC R, 5(7), 1999, pp. 1918-1924
Authors:
Hiltbold, EM
Alter, MD
Ciborowski, P
Finn, OJ
Citation: Em. Hiltbold et al., Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken up by dendritic cells, CELL IMMUN, 194(2), 1999, pp. 143-149
Authors:
Ciborowski, P
Hiltbold, EM
Barratt-Boyes, SM
Finn, OJ
Citation: P. Ciborowski et al., MUC1 mucin as a tumor antigen in breast cancer, CONT CANC R, 3, 1999, pp. 453-468
Risultati:
1-15
|